Mostrando 5 resultados de: 5
Filtros aplicados
Subtipo de publicación
Article(5)
Publisher
BMC Medicine(1)
Nature Communications(1)
Nature Medicine(1)
The Lancet Infectious Diseases(1)
The Lancet Regional Health - Americas(1)
Área temáticas
Medicina y salud(4)
Enfermedades(2)
Farmacología y terapéutica(2)
Medicina forense; incidencia de enfermedades(2)
Derecho(1)
Origen
scopus(5)
Duration of protection of CoronaVac plus heterologous BNT162b2 booster in the Omicron period in Brazil
ArticleAbstract: To date, no information has been published on the effectiveness of inactivated whole-virus COVID-19Palabras claves:Autores:Barral-Netto M., Boaventura V.S., Cerqueira-Silva T., de Araujo Oliveira V., Júnior J.B.S., Mauricio L. Barreto, Paixão E.S., Pearce N., Penna G.O., Werneck G.L.Fuentes:scopusEffectiveness of CoronaVac, ChAdOx1 nCoV-19, BNT162b2, and Ad26.COV2.S among individuals with previous SARS-CoV-2 infection in Brazil: a test-negative, case-control study
ArticleAbstract: Background: COVID-19 vaccines have proven highly effective among individuals without a previous SARSPalabras claves:Autores:Andrews J.R., Barral-Netto M., Boaventura V.S., Cerqueira-Silva T., Croda J., Cummings D.A.T., de Araujo Oliveira V., Dean N.E., Dorion M., Hitchings M.D.T., Júnior J.B.S., Ko A.I., Lind M.L., Machado T.M., Mauricio L. Barreto, Paixão E.S., Pearce N., Penna G.O., Ranzani O.T., Werneck G.L.Fuentes:scopusInfluence of age on the effectiveness and duration of protection of Vaxzevria and CoronaVac vaccines: A population-based study
ArticleAbstract: Background: Aging influences COVID-19 severity and response to vaccination, but previous vaccine effPalabras claves:CoronaVac, covid-19, EFFECTIVENESS, Vaccine, VaxzevriaAutores:Barral-Netto M., Boaventura V.S., Cerqueira-Silva T., de Barros J.V., Flores-Ortiz R.J., Ichihara M.Y.T., Júnior J.B.S., Machado T.M., Mauricio L. Barreto, Oliveira V.D.A., Penna G.O., Pescarini J.M., Werneck G.L.Fuentes:scopusVaccine effectiveness of heterologous CoronaVac plus BNT162b2 in Brazil
ArticleAbstract: There is considerable interest in the waning of effectiveness of coronavirus disease 2019 (COVID-19)Palabras claves:Autores:Barral-Netto M., Boaventura V.S., Cerqueira-Silva T., de Araujo Oliveira V., Flores-Ortiz R.J., Júnior J.B.S., Katikireddi S.V., Mauricio L. Barreto, Paixão E.S., Pearce N., Penna G.O., Robertson C., Sheikh A., Werneck G.L.Fuentes:scopusPrevious BCG vaccination is associated with less severe clinical progression of COVID-19
ArticleAbstract: Background: BCG vaccination, originally used to prevent tuberculosis, is known to “train” the immunePalabras claves:Bacillus Calmette-Guérin, BCG, coronavirus disease 2019, covid-19, SARS-COV-2, severity, VaccinationAutores:Abubakar I., Barral-Netto M., Barreto F.R., da Natividade M.S., da Paixão E.S., Dalcolmo M., de Alencar Ximenes R.A., de Andrade K.V.F., de Britto E.A., de Jesus Lima C.C.O., de Souza F.M., de Souza R.A., de Souza Teles Santos C.A., Fernandes E.G., Ichihara M.Y., Junior E.B.C., Lindoso A.A.B.P., Mauricio L. Barreto, Nunes C., Pereira M., Pereira S.M., Pescarini J.M., Rodrigues L.C., Trajman A.Fuentes:scopus